News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,509 Results
Type
Article (14345)
Company Profile (281)
Press Release (254883)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79718)
Career Advice (152)
Deals (13248)
Drug Delivery (35)
Drug Development (50703)
Employer Resources (31)
FDA (5779)
Job Trends (5261)
News (144993)
Policy (10123)
Tag
Academia (923)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21752)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5810)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4705)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (157)
Cancer (1499)
Cardiovascular disease (117)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (331)
Cervical cancer (10)
Clinical research (41321)
Collaboration (543)
Compensation (258)
Complete response letters (13)
COVID-19 (1038)
CRISPR (42)
C-suite (164)
Cystic fibrosis (76)
Data (1536)
Denatured (11)
Depression (30)
Diabetes (140)
Diagnostics (1307)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29898)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48753)
Executive appointments (464)
FDA (6482)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (499)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1090)
Grass and pollen (2)
Guidances (22)
Healthcare (6642)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (21)
Infectious disease (1103)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7279)
IRA (11)
Job creations (862)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1390)
Liver cancer (33)
Lung cancer (210)
Lymphoma (106)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (53)
Medical device (2620)
Medtech (2621)
Mergers & acquisitions (6300)
Metabolic disorders (391)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1257)
NextGen: Class of 2025 (2033)
Non-profit (856)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (64)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25682)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14554)
Phase II (19172)
Phase III (12224)
Pipeline (809)
Policy (45)
Postmarket research (856)
Preclinical (6147)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (292)
Real estate (1423)
Recruiting (12)
Regulatory (8724)
Reports (16)
Research institute (946)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (213)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (97)
Last 7 days (523)
Last 30 days (1522)
Last 365 days (19643)
2025 (6311)
2024 (20641)
2023 (22507)
2022 (26896)
2021 (27874)
2020 (23450)
2019 (16380)
2018 (11844)
2017 (13815)
2016 (11923)
2015 (14436)
2014 (10482)
2013 (7524)
2012 (7585)
2011 (7663)
2010 (7460)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (54)
Arkansas (5)
Asia (17374)
Australia (2938)
California (3874)
Canada (1141)
China (362)
Colorado (149)
Connecticut (152)
Delaware (103)
Europe (37326)
Florida (466)
Georgia (116)
Idaho (16)
Illinois (234)
India (10)
Indiana (91)
Iowa (2)
Japan (77)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (474)
Massachusetts (3085)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (996)
New Mexico (12)
New York (1048)
North Carolina (554)
North Dakota (5)
Northern California (1707)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (741)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1491)
Tennessee (25)
Texas (449)
United States (13323)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (352)
Wisconsin (15)
269,509 Results for "hls therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HLS Therapeutics to Host Q1 2025 Financial Results Conference Call
April 24, 2025
·
1 min read
Press Releases
HLS Therapeutics Appoints Christine Elliott to its Board of Directors
March 13, 2025
·
4 min read
Press Releases
HLS Therapeutics to Host Fiscal 2024 Financial Results Conference Call
February 28, 2025
·
1 min read
Press Releases
HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid
March 14, 2025
·
20 min read
Press Releases
HLS Therapeutics Announces Q3 2024 Financial Results
November 8, 2024
·
18 min read
Press Releases
HLS Therapeutics to Host Q3 Fiscal 2024 Financial Results Conference Call
October 24, 2024
·
1 min read
Press Releases
HLS Therapeutics Announces Q2 2024 Financial Results
August 8, 2024
·
18 min read
Press Releases
HLS Therapeutics to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
August 28, 2024
·
1 min read
Press Releases
HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call
July 25, 2024
·
1 min read
Press Releases
HLS Announces Reimbursement for Vascepa® under Alberta’s Provincial Drug Plan
July 29, 2024
·
4 min read
1 of 26,951
Next
